Kissei Pharmaceutical Plans Share Buyback and Cancellation
Company Announcements

Kissei Pharmaceutical Plans Share Buyback and Cancellation

Kissei Pharmaceutical Co (JP:4547) has released an update.

Kissei Pharmaceutical Co., Ltd. has announced its decision to acquire up to 1,400,000 of its own shares, representing 3.17% of the total issued shares, as part of a strategy to enhance capital efficiency and shareholder returns. The transaction will be conducted through the Tokyo Stock Exchange’s off-auction trading system, with a maximum acquisition cost set at 5.29 billion yen. The company also plans to cancel all treasury shares acquired during this process by November 29, 2024.

For further insights into JP:4547 stock, check out TipRanks’ Stock Analysis page.

Related Articles
Carrie WilliamsKSPHF Earnings this Week: How Will it Perform?
TipRanks Japan Auto-Generated NewsdeskKissei Pharmaceutical Launches YSELTY in Europe
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App